Faculty

Emily is a Principal Investigator in Translational Diagnostics at the Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, where she leads programmes spanning the end-to-end development, evaluation, and implementation of diagnostics for epidemic-prone diseases and global health security.

Concurrently, she is the Chief Global Health Officer at Global Access Diagnostics (GADx), a social enterprise diagnostic development company, where she leads the global health portfolio and oversees the translation of diagnostic innovations into accessible, affordable products. This includes strategic oversight of product pipelines and partnerships with IPD, DiaTROPIX and other local manufacturing partners for deployment at scale in LMIC settings.